Rectal cancer patients who ‘watch and wait’ may only need few years of stringent follow-up

An international team of scientists, including doctors from the Champalimaud Clinical Centre, in Lisbon, has just published results in the prestigious journal The Lancet Oncology that suggest that the majority of rectal cancer patients may be able, in the not so distant future, to replace aggressive colorectal surgery with a course of radiochemotherapy and few years of close surveillance. All […]

Continue reading »

Peripheral neuropathy linked to mortality in U.S. population

(HealthDay)—Peripheral neuropathy (PN) is associated with mortality, even among individuals without diabetes, according to a study published online Dec. 8 in the Annals of Internal Medicine. Caitlin W. Hicks, M.D., from the Johns Hopkins University School of Medicine in Baltimore, and colleagues examined the associations between PN and all-cause and cardiovascular mortality in a prospective cohort study involving 7,116 U.S. […]

Continue reading »

Baricitinib plus remdesivir shows promise for treating COVID-19

The combination of baricitinib, an anti-inflammatory drug, and remdesivir, an antiviral, reduced time to recovery for people hospitalized with COVID-19, according to clinical trial results published in the New England Journal of Medicine. The study was supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The clinical trial is the second […]

Continue reading »

1990 to 2019 Saw Increase in Global Burden of CVD

FRIDAY, Dec. 11, 2020 — From 1990 to 2019, there was an increase in the burden of cardiovascular disease (CVD) globally, according to a study published online Dec. 9 in the Journal of the American College of Cardiology. Gregory A. Roth, M.D., M.P.H., from the University of Washington in Seattle, and colleagues used data from the Global Burden of Disease […]

Continue reading »
1 1,067 1,068 1,069 1,070 1,071 1,322